rJararacin, a recombinant disintegrin from Bothrops jararaca venom: Exploring its effects on hemostasis and thrombosis - David et al., 2023.
Answers to your questions about the VenaFlux Solutions : Frequently Asked Questions (FAQs)
The rate of platelet activation determines thrombus size and structure at arterial shear
New insights into prothrombotic state of post-COVID syndrome patients
Cardiovascular: Stents; Drug Eluting Stents; Platelet Adhesion
VenaFlux Solutions for Thrombosis assay : Technical Specifications
Getting started with Cellix's Vena8 Glass Coverslip Biochips
VenaDeltaY Biochips: for dual flow / dual injection of samples
VenaT4 Biochip: for cell migration, transmigration, invasion and chemotaxis studies
Vena8 Fluoro+ Biochip: for cell receptor–ligand studies with conditions mimicking physiological flow
Intravenous abciximab as a rescue therapy in stroke patients
How to conduct a thrombosis assay using Mirus Evo or ExiGo Pump?
VenaFlux Solutions for Thrombosis assay : How does it work?
VenaFlux for thrombosis: Installation and training guide
Interference of C604 on platelet aggregation pathways
VenaFlux : Accessories required to conduct a thrombosis assay using the VenaFlux setup
Cellix's VenaFlux Solutions mimic human blood vessels
Selective Adenosine Receptor (AR) ligands modulate AR activity showing promise as clinical candidate
Bleeding diathesis in mice lacking JAK2 in platelets
Inhibition of NADPH oxidase blocks NETosis & reduces thrombosis in heparin-induced thrombocytopenia